Sumitomo Mitsui Ds Asset Management Company, LTD Gilead Sciences, Inc. Transaction History
Sumitomo Mitsui Ds Asset Management Company, LTD
- $9.15 Billion
- Q3 2024
A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 152,398 shares of GILD stock, worth $14.1 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
152,398
Previous 164,139
7.15%
Holding current value
$14.1 Million
Previous $11.3 Million
13.44%
% of portfolio
0.14%
Previous 0.13%
Shares
29 transactions
Others Institutions Holding GILD
# of Institutions
1,925Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.7 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.07 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.71 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.56 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $116B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...